Nerium Biotechnology
Nerium Biotech, a US-based company, develops oleander-based products for treating cancer, HIV/AIDS, Hepatitis C, and aging skin.
Founded
2006Nerium Biotech, a US-based company, develops oleander-based products for treating cancer, HIV/AIDS, Hepatitis C, and aging skin.
Founded in San Antonio, Nerium Biotechnology, Inc. is dedicated to developing oleander-based products aimed at treating cancer, HIV/AIDS, Hepatitis C, and aging skin. Their core mission is to harness the therapeutic potential of oleander to address proliferative diseases and viral infections. Key products include Anvirzel for cancer treatment, HIviral for HIV/AIDS, HEP-viral for Hepatitis C, and NeriumAD, an age-defying skin cream. The company focuses on the biotechnology and healthcare markets.
Nerium Biotechnology has garnered attention for its innovative approach to leveraging oleander in medical treatments. While specific notable affiliated people and investors are not detailed, the company's achievements include the development of a diverse product line addressing critical health issues. The impact of Nerium Biotech lies in its potential to offer alternative treatments for serious diseases, contributing to advancements in medical research and patient care.
Companies similar to Nerium Biotechnology include Phoenix Biotechnology, Nerio Therapeutics, Nerx Biosciences and Puma Biotechnology.
Nerium Biotechnology was founded in 2006.
Nerium Biotechnology's headquarters is located in San Antonio, TX, US.
Nerium Biotechnology's most recent funding round was for $288.5k (USD) in March 2011.
As of Mar 31, 2011, Nerium Biotechnology has disclosed funding of $288.5k (USD). Undisclosed round amounts are excluded.
Nerium Biotechnology has 33 employees as of Feb 5, 2024.
